Navigation Links
Inverness Medical Innovations to Present at RBC Capital Markets 2008 Healthcare Conference on December 11, 2008
Date:12/4/2008

WALTHAM, Mass., Dec. 4 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA), a leading provider of near-patient diagnostics, monitoring and health management solutions, announced today that Jon Russell, Vice President, Finance, will attend the upcoming RBC Capital Markets 2008 Healthcare Conference being held December 10-11, 2008 at the Westin Times Square Hotel in New York. Mr. Russell's presentation is scheduled for Thursday, December 11, 2008 at 9:00 a.m. and will be made available to the public through a webcast accessible through the Company's website at http://www.invmed.com/investors.cfm and through RBC Capital Markets' website at http://www.wsw.com/webcast/rbc95/panel21/. A replay of the webcast will be available via the links above for 30 days. During his presentation, Mr. Russell may discuss and answer questions concerning business and financial developments and trends. His responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.

For more information about Inverness Medical Innovations, please visit our website at www.invernessmedical.com.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Inverness Medical Innovations, PrognostiX Sign Distribution Agreement for CardioMPO(TM) Test
2. Inverness Medical Innovations to Present at the Third Annual JMP Securities Healthcare Focus Conference on October 7, 2008
3. Inverness Medical Innovations Announces 4th Generation Rapid HIV Test - Determine(TM) HIV-1/2 Ag/Ab Combo
4. Law Offices of Howard G. Smith Announces 24 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Inverness Medical Innovations, Inc.
5. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET April 24, 2008 to Discuss First Quarter 2008 Results
6. Correction: Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Inverness Medical Innovations, Inc.
7. Law Offices of Howard G. Smith Announces Investigation on Behalf of Current and Former Employees of Inverness Medical Innovations, Inc. Who Invested in the Inverness Medical Innovations, Inc. Employee Savings Plan
8. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 20, 2008 to Discuss Fourth Quarter 2007 Results
9. Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13, 2008
10. Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.
11. Inverness Medical Innovations to Acquire Redwood Toxicology Laboratory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...t kit called DrugConfirm™ ,is the ideal drug... and accurate instant drug test. Developed by Biot...ek, innovative design and incorporates new Push Bu...y priced compared to the other urine cup products ... San Diego (Vocus) – A n...
(Date:7/3/2009)...home medical services provider specializing in inf...ervices, is expanding. Two new pharmacies in Roche...sion therapy and one in oral medication, a new pro... Clinton, NY (PRWEB) June 22, 2009 -- Ups...pecializing in infusion, specialty medication, res...
(Date:7/2/2009)...swire/ -- Acetaminophen is an ingredient found in ...o help relieve pain and reduce fever. Many people...nd prescription brand names, Vicodin and Percocet....June 30, 2009 to address liver related injuries du...d 20-17 to urge the FDA to put a ban on Vicodin an...
(Date:7/2/2009)..., expert says , , THURSDAY, July 2 (Heal... species of wildlife, which need to be protected t...ancer is one of the leading health concerns for hu... deaths. But we now understand that cancer can kil...se McAloose, chief pathologist for the Wildlife Co...
Breaking Medicine News(10 mins):Health News:New Urine Drug Test to Detect for 6 Major Drugs, Now Available at Drugstore.com -- 'DrugConfirm' Is a New Revolutionary Urine Drug Test 2Health News:New Urine Drug Test to Detect for 6 Major Drugs, Now Available at Drugstore.com -- 'DrugConfirm' Is a New Revolutionary Urine Drug Test 3Health News:Upstate HomeCare Expands, Adds Pharmacies 2Health News:Upstate HomeCare Expands, Adds Pharmacies 3Health News:Viles & Beckman, LLC: Stop Your Headache NOT Your Liver 2Health News:Cancer Endangers Some Wildlife Species 2
...lines for patients with low levels of good cholest...d arteries. The article will be published in The N...earchers report that existing strategies to preven...e best means to raise HDL cholesterol and instead ...
...e over the past fifty years, new nutrition-related...nsition has and is occurring on a continuum. While...onal status continue to exist, increasingly proble...ficant public health issues globally. A demographi...
...er Center, New York has reported that Women with a...RCA1 and BRCA2 breast cancer gene mutation do not ...ncer. The study was conducted in 200 families with...eports submitted in the Journal of the National Ca...
...hundreds of elderly people may be a long way off, ... keep patients mentally agile and slow the crippli...heimer's is a disease and not a normal process of ...nd slowing down of activities. Once the early stag...
Other Medicine News:Health News:Experts State Strategies To Increase Good Cholesterol 2Health News:Active Lifestyle Helps To Slowdown Illness In Alzheimer's Patients 2
(Date:6/29/2009)... June 29 Vantia Therapeutics, an,...small molecule drugs,targeting large, underserved...,a Phase IIa clinical trial of its lead developmen...d that oral VA106483 was successful in producing a...n patients, as determined by,increased osmolality...
(Date:6/26/2009)...6 Sanofi-aventis (EURO...re of data associated with a retrospective follow-...e data clearly show that no definitive conclusions...ship between Lantus(R) (insulin glargine [rDNA] in...s the authors of the study point out. , , Clini...
(Date:6/25/2009)...wire-USNewswire/ -- As of mid-2009, The Michael J....dy funded over $1 million in high-risk, high-rewar...t through its groundbreaking Rapid Response Innov...the safety and efficacy of an FDA-approved drug fo...ation of a tenuous link between PD and certain str...
(Date:6/24/2009)... 25 , - Recruitme...e,Non-Surgical Treatment of Eye Disease With No R...uronext Brussels: THR), a biotechnology company,f...ive treatments for eye,disease, vascular disease ...,microplasmin, which is in Phase III trials for th...
Breaking Medicine Technology:Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Sanofi-aventis Stands Behind the Safety of Lantus(R) 2Sanofi-aventis Stands Behind the Safety of Lantus(R) 3MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 2MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 3ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule 2ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule 3InVitria Reveals Technology to Optimize Hybridoma Production Performance 43244 1InVitria Reveals Technology to Optimize Hybridoma Production Performance 43244 2Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 1Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 2Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 3Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 4Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 5Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 6Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 7Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 8Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 9Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 10Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 11Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 12Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 13New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin 43241 1New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin 43241 2New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin 43241 3New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin 43241 4University of Texas at Austin engineer elected to American Academy of Arts and Sciences 8122 1University of Texas at Austin engineer elected to American Academy of Arts and Sciences 8122 2University of Texas at Austin engineer elected to American Academy of Arts and Sciences 8122 3
... Potent Synergy, Activity and Patient Tolerance Su...ry Therapy, BARCELONA, Spain, April 12, 2007 /PRNe...y held biopharmaceutical company,today announced ...eron with or without ribavirin in treatment-naive ...results demonstrate that,omega interferon in combi...
... SOUTH SAN FRANCISCO, Calif., April 11, 2007 (PRI...biopharmaceutical company focused,on advancing can...ta(tm) (talotrexin) for Injection at the American ...ng April 14-18, 2007 in Los,Angeles, California. ,... with,paclitaxel in A549 non-small cell lung cance...
Other Medicine Technology:Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 2Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 3Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 4Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 2Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 3
Disposable Microscissors: Horizontal Curved Microscissors
Sharp tipped illuminated scissors with a curvature of 12 mm to follow the contour of the retina. For cutting in the plane parallel to the retina, cutting membranes adherent to the retinal surface and
Disposable Microscissors: Vertical, 90
Sharp tipped scissors with a curvature of 12 mm to follow the contour of the retina. For cutting in the plane parallel to the retina, cutting membranes adherent to the retinal surface and all purpose
Medicine Products: